Transaction · 0001384243-26-000002

Quart Barry D

Quart Barry D, DIR, reported an open-market or private sale at Kiniksa Pharmaceuticals International, plc involving 2602.000000 shares for an estimated $117142.04. Reported holdings after the transaction were 12546.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
KNSAKiniksa Pharmaceuticals International, plc
Filing timeFeb 04
Trade dateFeb 04, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$43.52
Pre-filing
1mo ago -5.7%1w ago -0.6%1d ago +3.3%
Returns since
7d +3.4%30d +6.1%90d +30.4%180d +68.7%1y +79.4%

KNSA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
KNSA since 2026-02-04Filed 212 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001384243-26-000002
Class A Ordinary Share
Transaction date
Feb 04, 2026
Filed Feb 04, 2026, 11:24 PM · 0d delay
Shares
2.60k sh
$4.50k per share
Estimated value
-$11.7M
Computed from shares × price
Holdings after
12.5k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.

  2. F2

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.02. The price reported in this column reflects a weighted average sales price. Upon re…

  3. F3

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.48. The price reported in this column reflects a weighted average sales price. Upon re…

  4. F4

    This transaction was executed in multiple trades through a broker-dealer at prices ranging between $45.00 and $45.05. The price reported in this column reflects a weighted average sales price. Upon re…

  5. F5

    The option is fully vested and exercisable.

Original filing · 0001384243-26-000002
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

KNSA